N-((1-((1-benzylpiperidin-4-yl)methyl)-3-(3-carbamimidoylphenyl)-2-oxohexahydropyrimidin-5-yl)methyl)-2-phenylacetamide

ID: ALA3780269

Chembl Id: CHEMBL3780269

PubChem CID: 118548776

Max Phase: Preclinical

Molecular Formula: C33H40N6O2

Molecular Weight: 552.72

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  N=C(N)c1cccc(N2CC(CNC(=O)Cc3ccccc3)CN(CC3CCN(Cc4ccccc4)CC3)C2=O)c1

Standard InChI:  InChI=1S/C33H40N6O2/c34-32(35)29-12-7-13-30(19-29)39-24-28(20-36-31(40)18-25-8-3-1-4-9-25)23-38(33(39)41)22-27-14-16-37(17-15-27)21-26-10-5-2-6-11-26/h1-13,19,27-28H,14-18,20-24H2,(H3,34,35)(H,36,40)

Standard InChI Key:  JHARRMAYSVPENO-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA3780269

   N-[[1-[(1-benzylpiperidin-4-yl)methyl]-3-(3-carbamimidoylphenyl)-2-oxo-1,3-diazinan-5-yl]methyl]-2-phenylacetamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 552.72

Molecular Weight (Monoisotopic): 552.3213

AlogP: 4.10

#Rotatable Bonds: 10

Polar Surface Area: 105.76

Molecular Species: BASE

HBA: 4

HBD: 3

#RO5 Violations: 1

HBA (Lipinski): 8

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 1

CX Acidic pKa: ┄

CX Basic pKa: 11.17

CX LogP: 3.06

CX LogD: -0.85

Aromatic Rings: 3

Heavy Atoms: 41

QED Weighted: 0.26

Np Likeness Score: -1.12

References

1. Venukadasula PK, Owusu BY, Bansal N, Ross LJ, Hobrath JV, Bao D, Truss JW, Stackhouse M, Messick TE, Klampfer L, Galemmo RA..  (2016)  Design and Synthesis of Nonpeptide Inhibitors of Hepatocyte Growth Factor Activation.,  7  (2): [PMID:26985294] [10.1021/acsmedchemlett.5b00357]

Source

Source(1):

• Scientific Literature